Barry Cohen

Barry Cohen

Barry Cohen has nearly 30 years in communications and marketing, the majority in senior positions at three large international health care companies – Abbott Laboratories, Warner-Lambert (now part of Pfizer) and Bayer, Inc.

At Abbott, Cohen was a member of the company’s investor relations team, responsible for preparing all financial analyst presentations. He also oversaw the company’s award-winning annual and quarterly reports and was responsible for both the company’s investor seminar and annual shareholders’ meeting.

After relocating to Arizona, Cohen served as editor of M.D. News, a magazine for Phoenix-area physicians. Later he was a reporter for a weekly newspaper in a north Phoenix, where he specialized in business articles and profiles of local publicly traded companies.

To further his knowledge and understanding of financial markets, Cohen earned a series 7 broker’s license and was employed at Charles Schwab as a registered representative.  He returned to the communications field with CPRi Communications, where he wrote numerous case studies and bylined articles for the company’s clients in the health care information technology industry. Later, he worked for a Scottsdale, Ariz.-based investment bank preparing profiles of companies being offered for sale.

Recent Articles

Novartis Shifts Strategy to Reinforce Growth

Can Novartis' focus on generics and emerging markets counteract the loss of key patent protections?

Alkermes Looks to Enter Biotech Big Leagues

CEO orchestrates a transformation that could leave the company poised for further growth.

Drug Wholesalers Should Win Big From Generics Boom

Several big blockbuster drugs will soon lose their patent protection. These three companies can expect to enjoy steep paydays as a result.

Big Pharma Betting on Cancer-Drug Paydays

New revenue streams are needed to offset patent losses.

Regeneron Rally May Ride on Blindness Drug

A new revenue stream could mean a big boost for this stock.